Continuous subcutaneous insulin infusion for the treatment of diabetic patients with hypoglycemia unawareness

I. B. Hirsch, R. Farkas-Hirsch, P. E. Cryer

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

We describe two patients with hypoglycemia unawareness complicated by gastroparesis, hypoglycemia unawareness and defective glucose counterregulation. Both suffered recurrent severe hypoglycemia despite a basal-bolus (ultralente and regular insulin) regimen, frequent self blood glucose monitoring and intent to keep preprandial blood glucose levels above 6.7 mmol/l (120 mg/dl). The frequency of severe hypoglycemia was reduced after institution of continuous subcutaneous insulin infusion (CSII) with no change in overall glycemic control as indicated by glycated hemoglobin measurements. Thus, it appears that CSII need not be limited to attempts to achieve near-normal glycemia in IDDM. It may also be useful to produce relatively stable glycemia and thus reduce the frequency of severe hypoglycemia in patients in whom complications that predispose to the latter are disabling.

Original languageEnglish
Pages (from-to)41-43
Number of pages3
JournalDiabetes, Nutrition and Metabolism - Clinical and Experimental
Volume4
Issue number1
StatePublished - Jun 7 1991

Fingerprint Dive into the research topics of 'Continuous subcutaneous insulin infusion for the treatment of diabetic patients with hypoglycemia unawareness'. Together they form a unique fingerprint.

Cite this